The latest market report published by Credence Research, Inc. Global Neurological Diseases Treatment Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2017 - 2025, the Neurological Diseases Treatment market was valued at USD 75.3 Bn in 2016, and is expected to reach USD 130.8 Bn by 2025, expanding at a CAGR of 6.2% from 2017 to 2025.

Browse the full report Neurological Diseases Treatment Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2017 2025 report athttp://www.credenceresearch.com/report/neurological-diseases-treatment-market

Market Insights

A neurological disorder is any medical complication that affects the nervous system that includes your brain, spinal cord, and other nerves. According to medical experts, symptoms of a neurological disorder are possibly mild, such as muscle weakness, poor coordination, or changes in thinking patterns. It was also observed that in some cases symptoms are usually more noticeable, such as seizures, pain, and intellectual disability. According to the World Health Organization (WHO), the cerebrovascular diseases, which can manifest as a stroke, migraine, or headache is the common cause of concern for several patients. In addition to that about 80% of patients suffering from cerebrovascular diseases across the world have these symptoms.

In year 2016, Alzheimers and Parkinsons disease accounted for more than 50% of the market share together due to rising prevalence of these diseases, introduction of novel diagnostic technology for neurological diseases, and rising awareness programs organized by governmental and non-governmental organizations. In case of market segmentation by drug class anticholinergic and antiepileptic drugs accounted for around 42% of the market share together in 2016. The key driving factors assisting the growth of these two segments are rising prevalence of neurological diseases, incessant development in diagnostic technology, and rising awareness associated with early disease diagnosis through awareness campaigns carried out by governmental or non-governmental organizations. However, market entry of efficient drugs in the near future due to presence of strong drug pipeline is expected to change the market share of traditional drug treatments and further boost the overall growth of this market.

North America accounted for the largest share in global neurological diseases treatment market due to key driving factors such as rising prevalence of neurological diseases, rising awareness associated with early neurological disease diagnosis and treatment, supportive reimbursement policies, and incessant developments in the field of research and development. During the forecast period 2017 2025, Asia Pacific was observed as the fastest growing region due to key driving factors such as increasing prevalence of neurological disorders, developing healthcare infrastructure, rising awareness associated with neurological diseases which is fueling the rate of diagnosis, and mounting accessibility of modern treatments in developing countries such as China, India, and Indonesia.

Market Competition Assessment:

The neurological diseases treatment market is observed as the most diversified and competitive market comprising large number of players.  The market is dominated by several players, depending on their major competencies. The key players in this market are Merck & Co., Boehringer Ingelheim GmbH, Bayer AG, Astra Zeneca, F-Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd., and GlaxoSmithKline plc among others.

Key Market Movements:

• Rising prevalence of neurological diseases coupled with increasing awareness associated with the disease diagnosis in developing countries is assisting the market growth
• High awareness associated with early cancer diagnosis and availability of advanced diagnostic techniques is also due to number of awareness campaigns organized by governmental and non-governmental organizations worldwide 

Browse the full report Neurological Diseases Treatment Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2017 2025 report athttp://www.credenceresearch.com/report/neurological-diseases-treatment-market

A neurological disorder is any disorder of the nervous system. Structural, biochemical or electrical abnormalities in the brain, spinal cord or other nerves can result in a range of symptoms. Examples of symptoms include paralysis, muscle weakness, poor coordination, loss of sensation, seizures, confusion, pain and altered levels of consciousness. There are many recognized neurological disorders, some relatively common, but many rare. They may be assessed by neurological examination, and studied and treated within the specialities of neurology and clinical neuropsychology.

Interventions for neurological disorders include preventative measures, lifestyle changes, physiotherapy or other therapy, neurorehabilitation, pain management, medication, or operations performed by neurosurgeons. The World Health Organization estimated in 2006 that neurological disorders and their sequelae (direct consequences) affect as many as one billion people worldwide, and identified health inequalities and social stigma/discrimination as major factors contributing to the associated disability and suffering. Source: Wikipedia

 Blog: https://globenewswire.com/news-release/2018/03/08/1418682/0/en/Custom-T-shirt-Printing-Market-is-Expected-To-Cross-US-10-Billion-by-2025-Credence-Research.html

About:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared for this task.

Media Contact
Name: Chris Smith
Address: 105 N 1st ST #429
SAN JOSE, CA 95103 US
E-mail: sales@credenceresearch.com
Ph: 1-800-361-8290
Web: http://www.credenceresearch.com